BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 6619033)

  • 1. Evaluation of azlocillin in vitro and in discriminative animal models of infection.
    Scheld WM; Brodeur JP; Keeley JM; Field MR; Kelly WJ; Long WJ; Zak O
    J Antimicrob Chemother; 1983 May; 11 Suppl B():51-68. PubMed ID: 6619033
    [No Abstract]   [Full Text] [Related]  

  • 2. Evaluation of mezlocillin in discriminative animal models of infection.
    Scheld WM; Brodeur JP; Keeley JM
    J Antimicrob Chemother; 1982 Jan; 9 Suppl A():51-64. PubMed ID: 6210683
    [No Abstract]   [Full Text] [Related]  

  • 3. Activities of tobramycin and azlocillin alone and in combination against experimental osteomyelitis caused by Pseudomonas aeruginosa.
    Norden CW; Shaffer MA
    Antimicrob Agents Chemother; 1982 Jan; 21(1):62-5. PubMed ID: 6805423
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Evaluation of the clinical activity of azlocillin. A multicenter study conducted in 14 centers].
    Konopka CA
    Presse Med; 1984 Mar; 13(13):808-11. PubMed ID: 6231600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative clinical evaluation of azlocillin and gentamicin.
    Sabbaj J; Torres M; Loza L
    J Antimicrob Chemother; 1983 May; 11 Suppl B():175-81. PubMed ID: 6619027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [For which infections is the use of antibiotic combinations today considered scientifically justified?].
    Modde H
    Fortschr Med; 1972 Aug; 90(24):827-9. PubMed ID: 4639344
    [No Abstract]   [Full Text] [Related]  

  • 7. Evaluation of quinolones in experimental animal models of infections.
    Scheld WM
    Eur J Clin Microbiol Infect Dis; 1991 Apr; 10(4):275-90. PubMed ID: 1864288
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pseudomonas aeruginosa meningitis treated with an azlocillin combination.
    Davidson S; Yellin EO; Shaked I; Rubinstein E
    Infection; 1982; 10 Suppl 3():S168-9. PubMed ID: 6818154
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pseudomonas meningitis treated with azlocillin.
    Ellis CJ; Walter PH
    Br Med J; 1979 Sep; 2(6193):767. PubMed ID: 519187
    [No Abstract]   [Full Text] [Related]  

  • 10. [Pseudomonas aeruginosa meningitis treated with azlocillin. 5 cases].
    Vilde JL; Vachon F; Humbert G; Bure A; Bricaire F
    Presse Med; 1984 Mar; 13(13):822-4. PubMed ID: 6231604
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of azlocillin to treat serious infections.
    Neu HC; Francke EL; Ortiz-Neu C; Prince AS
    J Antimicrob Chemother; 1983 May; 11 Suppl B():141-7. PubMed ID: 6619023
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical results with azlocillin (author's transl)].
    Schacht P; Tettenborn D; Hullmann R; Bruck H
    Arzneimittelforschung; 1979; 29(12a):1981-5. PubMed ID: 396929
    [No Abstract]   [Full Text] [Related]  

  • 13. A comparative study of the efficacy and safety of azlocillin and gentamicin in the treatment of serious infections.
    del Rosal PL
    J Antimicrob Chemother; 1983 May; 11 Suppl B():159-67. PubMed ID: 6352599
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of serious Pseudomonas infections with azlocillin.
    Olive S; Mogabgab WJ; Holmes B; Pollock B; Pauling B; Beville R
    J Antimicrob Chemother; 1983 May; 11 Suppl B():153-8. PubMed ID: 6619026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of therapeutic efficacy of ureidopenicillins in comparison to sisomicin and cephalotin in experimental infections of rabbits.
    Dzierzanowska D; Klosinska E; Roszkowski W; Patzer J; Jeljaszewicz J
    Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1981 Sep; 250(3):312-21. PubMed ID: 6458186
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Current aspects of pseudomonas meningitis].
    Brückner O; Borner K; Hoffmann HG; Trautmann M; Collmann H
    Neurochirurgia (Stuttg); 1985 Jan; 28(1):12-6. PubMed ID: 2983254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Successful treatment of neonatal Flavobacterium meningosepticum infection.
    Kaplan M; Goldberg MD; Tauber Z; Solomon F; Sompolinsky D
    Eur J Pediatr; 1983 Sep; 140(4):337-8. PubMed ID: 6628455
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo efficacy of azlocillin and amikacin versus ciprofloxacin with and without amikacin in experimental right-sided endocarditis due to Pseudomonas aeruginosa.
    Bayer AS; Kim KS
    Chemotherapy; 1986; 32(4):364-73. PubMed ID: 2942342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of ciprofloxacin in animal models of infection: endocarditis, meningitis, and pneumonia.
    Sande MA; Brooks-Fournier RA; Gerberding JL
    Am J Med; 1987 Apr; 82(4A):63-6. PubMed ID: 3578331
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Monotherapy of Pseudomonas aeruginosa septicemia with azlocillin].
    Godard J; Aubertin J; Borderon JC; Dureux JB; Motin J
    Presse Med; 1984 Mar; 13(13):819-21. PubMed ID: 6231603
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.